Apolipoprotein E genotype does not influence the progression of multiple sclerosis

Journal of Neurology

Volumn 250, Issue 9, 2003, Pages 1094-1098

  Savettieri, Giovanni ^a   Andreoli, Virginia ^b   Bonavita, Simona ^c   Cittadella, Rita ^b   Caltagirone, Carlo ^d   Fazio, Maria Carolina ^e   Girlanda, Paolo ^e   Le Pira, Francesco ^f   Liguori, Maria ^g   Logroscino, Giancarlo ^h   Lugaresi, Alessandra ⁱ   Nocentini, Ugo ^d   Reggio, Arturo ^f   Salemi, Giuseppe ^a   Serra, Paolo ^b   Tedeschi, Gioacchino ^c   Toma, Lucia ⁱ   Trojano, Maria ^g   Valentino, Paola ^j   Quattrone, Aldo ^b,j,k  

^a UNIVERSITY OF PALERMO   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e UNIVERSITY OF MESSINA   (Italy)

^f UNIVERSITY OF CATANIA   (Italy)

^g UNIVERSITY OF BARI   (Italy)

^h MIULLI GENERAL HOSPITAL   (Italy)

ⁱ UNIVERSITY OF CHIETI   (Italy)

^j UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^k Policlinico Mater Domini   (Italy)

more..

Author keywords

APOE polymorphism; APOE promoter; MS progression; Multiple sclerosis

Indexed keywords

ADENINE; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; GENE PRODUCT; THYMINE;

ADULT; ALLELISM; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE DURATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; RATING SCALE;

ADOLESCENT; ADULT; APOLIPOPROTEINS E; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; DISEASE PROGRESSION; FEMALE; GENOTYPE; HUMANS; MALE; MULTIPLE SCLEROSIS; ODDS RATIO; POLYMORPHISM, GENETIC; STATISTICS, NONPARAMETRIC;

EID: 0141832048     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-003-0163-8     Document Type: Article

References (23)

1. Ballerini C, Campani D, Rombola G, et al. (2000) Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis. Neurosci Lett 296:174-176
2. Broadley S, Sawcer S, D'Alfonso S, et al. (2001) A genome screen for multiple sclerosis in Italian families. Genes Immun 2:205-210
3. Chapman J, Vinokurov S, Achiron A, et al. (2001) APOE genotype is a major predictor of long-term progression of disability in MS. Neurology 56:312-316
4. Corbo RM, Scacchi R (1999) Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a "thrifty" allele? Ann Hum Genet 63:301-310
5. Evangelou N, Jackson M, Beeson D, et al. (1996) Association of the apoE epsilon 4 allele with disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 67:203-205
6. Fazekas F, Strasser-Fuchs S, Kollegger H, et al. (2001) Apolipoprotein E ε4 is associated with rapid progression of multiple sclerosis. Neurology 57:853-857
7. Ferri C, Sciacca FL, Veglia F, et al. (1999) APOE epsilon 2-4 and -491 polymorphisms are not associated with MS. Neurology 53:888-889
8. Haines IL, Bradford Y, Garcia ME, et al. (2002) Multiple susceptibility loci for multiple sclerosis. Hum Mol Genet 15:2251-2256
9. Høgh P, Oturai A, Schreiber K, et al. (2000) Apolipoprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate. Mult Scler 6:226-230
10. Kurtzke J (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
11. Lublin F, Reingold S (1996) Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46:907-911
12. Masterman T, Zhang Z, Hellgren D, et al. (2002) APOE genotypes and disease severity in multiple sclerosis. Mult Scler 8:98-103
13. Oliveri RL, Cittadella R, Sibilia G, et al. (1999) APOE and risk of cognitive impairment in multiple sclerosis. Acta Neurol Scand 100:290-295
14. Panza F, Solfrizzi V, Torres F, et al. (1999) Decreased frequency of apolipoprotein E epsilon4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians. Neurosci Lett 277:53-56
15. Poser S, Ritter G, Bauer HJ, et al. (1981) HLA-antigens and the prognosis of multiple sclerosis. J. Neurol 225:219-221
16. Poser C, Paty D, Scheinberg L, et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
17. Rubinsztein DC, Hanlon CS, Irving RM, et al. (1994) Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease. Mol Cell Probes. 8:519-525
18. Sawcer S, Maranian M, Setakis E, et al. (2002) A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility. Brain 125:1337-1347
19. Schmidt S, Barcellos LF, DeSombre K, et al. (2002) Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis. Hum Genet 70:708-717
20. Schreiber K, Otura AB, Ryder LP, et al. (2002) Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA- DRB1*1501, CCR5 deletion mutation, apolipoprotein E). Mult Scler 8:295-298
21. Town T, Paris D, Fallin D, et al. (1998) The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism. Neurosci Lett 252:95-98
22. Weatherby S, Mann C, Davies M, et al. (2000) Polymorphisms of apolipoprotein E: outcome and susceptibility in multiple sclerosis. Mult Scler 6:32-36
23. Weinshenker BG (1994) Natural history of multiple sclerosis. Brain 36:S6-S11